We are live on ! Find out more
OGEN icon

Oragenics
OGEN

14 hedge funds and large institutions have $6.46M invested in Oragenics in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more capital invested

Capital invested by funds: $2.48M → $6.46M (+$3.98M)

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

27% more funds holding

Funds holding: 11 → 14 (+3)

0.01% more ownership

Funds ownership: 0.01% → 0.01% (+0.01%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
14
Holders Change
+3
Holders Change %
+27.27%
% of All Funds
0.3%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
6
Increased
1
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
+$2.96M
2
AFM
Anson Funds Management
Texas
+$2.61M
3
HCS
Harvest Capital Strategies
California
+$1.17M
4
SM
Sabby Management
Florida
+$447K
5
Barclays
Barclays
United Kingdom
+$34.6K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$110K
2
TSS
Two Sigma Securities
New York
-$11K
3
IA
IFP Advisors
Florida
-$3K
4
UBS Group
UBS Group
Switzerland
-$1K

OGEN Hedge Fund Activity: Q1 2019 in Review

14 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q1 2019, worth a combined $6.46M — up 160% from $2.48M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new OGEN positions and 3 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was CVI Holdings, opening a new position worth an estimated $2.96M. The largest seller was Virtu Financial, cutting an estimated $110K.

  • 14 institutional investors held Oragenics (OGEN) as of Q1 2019, up from 11 in Q4 2018.
  • Funds reported $6.46M of Oragenics stock for Q1 2019, up 160% quarter-over-quarter.
  • 6 funds opened new Oragenics positions in Q1 2019 and 3 closed out, a net change of +3 holders.
  • The largest Oragenics buyer in Q1 2019 was CVI Holdings, an estimated $2.96M added.
  • The largest Oragenics seller in Q1 2019 was Virtu Financial, an estimated $110K sold.

Based on aggregated 13F filings for Q1 2019.